CA-A Cancer Journal for Clinicians

Papers
(The H4-Index of CA-A Cancer Journal for Clinicians is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries53206
Cancer Statistics, 202111472
Cancer statistics, 202210121
Cancer statistics, 20235166
Cancer treatment and survivorship statistics, 2022961
Management of glioblastoma: State of the art and future directions950
Current treatment and recent progress in gastric cancer768
Breast Cancer Statistics, 2022677
Cancer statistics for adolescents and young adults, 2020579
Treatment of muscle‐invasive and advanced bladder cancer in 2020495
Colorectal cancer statistics, 2023491
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society462
Brain and other central nervous system tumor statistics, 2021420
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations363
American Cancer Society guideline for diet and physical activity for cancer prevention346
Metabolomics in cancer research and emerging applications in clinical oncology281
Cancer statistics for African American/Black People 2022243
American Cancer Society nutrition and physical activity guideline for cancer survivors241
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma235
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions228
Cancer statistics for the US Hispanic/Latino population, 2021180
Clinical management of metastatic colorectal cancer in the era of precision medicine172
Cancer statistics, 2024162
150
Integrative oncology: Addressing the global challenges of cancer prevention and treatment146
Radiation therapy‐associated toxicity: Etiology, management, and prevention141
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies136
Molecular imaging in oncology: Current impact and future directions117
A systematic review of rehabilitation and exercise recommendations in oncology guidelines112
American Cancer Society's report on the status of cancer disparities in the United States, 2021108
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions100
Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation92
An update on the immune landscape in lung and head and neck cancers91
86
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians86
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach81
Onconephrology: The intersections between the kidney and cancer76
Intermittent fasting in the prevention and treatment of cancer75
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer74
73
Cervical cancer prevention and control in women living with human immunodeficiency virus72
Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit68
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward68
The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer67
Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review63
The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies60
Blueprint for cancer research: Critical gaps and opportunities51
Cancer epigenetics in clinical practice50
0.015093803405762